Open AccessModern opportunities for the diagnosis and treatment of vulvovaginal candidiasis (in aid of a practitioner)
Author(s) -
Э Р Довлетханова,
П. Р. Абакарова
Publication year - 2019
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2019-13-42-48
Subject(s) - vulvovaginal candidiasis , medicine , vaginitis , vaginal disease , dermatology , gynecology , vaginal infections , sexually active , intensive care medicine , family medicine , vagina , obstetrics , antifungal , surgery , human immunodeficiency virus (hiv)
Vulvovaginal candidiasis (VVC) is one of the most common vaginal infections, representing 40% to 50% of all cases of infectious vulvovaginitis. Between 70-75% of sexually active women experience at least one episode of VVC in their lifetime, and 8-10% of adult women have recurrent VVC. The treatment of VVC remains as one of the most pressing challenges of gynecology. The share of recurrent disease event rates remains high, despite the modern medicines used to treat various forms of VVC.